Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position - PubMed (original) (raw)
Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position
R C Hoeben et al. J Virol. 1991 Feb.
Abstract
The expression of a retroviral vector with the Moloney murine leukemia virus (Mo-MuLV) long terminal repeat (LTR) promoter after integration into the genome of murine fibroblast cell lines was monitored with the Escherichia coli-derived beta-galactosidase (beta-gal) gene as the reporter. Monoclonal cell lines derived after retroviral infection exhibited a marked heterogeneity in their expression of the reporter gene. We studied two monoclonal cell lines with a single unrearranged copy of the vector provirus integrated into their genome. The first, BB10, expressed the marker enzyme in only 8% of its cell population, whereas in the second, BB16, beta-gal expression could be detected in over 98% of the cells. Treatment of BB10 with the DNA-demethylating agent 5-azacytidine raised the number of beta-gal-positive cells to over 60%. Transfection experiments showed that the Mo-MuLV LTR promoter-enhancer is potentially fully functional in both the BB10 and BB16 cell lines. The inactivated provirus from BB10 cells was cloned and subsequently used to generate retrovirus stocks. The promoter-enhancer activity of its LTR after infection with these BB10-derived viruses showed a variation similar to that of the original virus stocks. Our data showed that (1) inactivation of the Mo-MuLV LTR is a frequent event in murine fibroblast cell lines, (2) inactivation is associated with de novo methylation of cytidine residues, (3) the frequency of inactivation of the provirus must be determined by its chromosomal position, (4) the process of methylation of sequences within the LTR is not necessarily the same as the transcription-repression mechanism that is operating in undifferentiated embryonal carcinoma cells.
Similar articles
- A single point mutation activates the Moloney murine leukemia virus long terminal repeat in embryonal stem cells.
Grez M, Zörnig M, Nowock J, Ziegler M. Grez M, et al. J Virol. 1991 Sep;65(9):4691-8. doi: 10.1128/JVI.65.9.4691-4698.1991. J Virol. 1991. PMID: 1870196 Free PMC article. - Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
Fan H, Mittal S, Chute H, Chao E, Pattengale PK. Fan H, et al. J Virol. 1986 Oct;60(1):204-14. doi: 10.1128/JVI.60.1.204-214.1986. J Virol. 1986. PMID: 3747027 Free PMC article.
Cited by
- Alpharetroviral vectors: from a cancer-causing agent to a useful tool for human gene therapy.
Suerth JD, Labenski V, Schambach A. Suerth JD, et al. Viruses. 2014 Dec 5;6(12):4811-38. doi: 10.3390/v6124811. Viruses. 2014. PMID: 25490763 Free PMC article. Review. - Dynamics and evolution of β-catenin-dependent Wnt signaling revealed through massively parallel clonogenic screening.
Shah PK, Walker MP, Sims CE, Major MB, Allbritton NL. Shah PK, et al. Integr Biol (Camb). 2014 Jul 24;6(7):673-84. doi: 10.1039/c4ib00050a. Epub 2014 May 28. Integr Biol (Camb). 2014. PMID: 24871928 Free PMC article. - Epigenetic changes of lentiviral transgenes in porcine stem cells derived from embryonic origin.
Choi KH, Park JK, Kim HS, Uh KJ, Son DC, Lee CK. Choi KH, et al. PLoS One. 2013 Aug 19;8(8):e72184. doi: 10.1371/journal.pone.0072184. eCollection 2013. PLoS One. 2013. PMID: 23977247 Free PMC article. - Reactivation of Silenced WT1 Transgene by Hypomethylating Agents - Implications for in vitro Modeling of Chemoimmunotherapy.
Kwon YR, Son MJ, Kim HJ, Kim YJ. Kwon YR, et al. Immune Netw. 2012 Apr;12(2):58-65. doi: 10.4110/in.2012.12.2.58. Epub 2012 Apr 30. Immune Netw. 2012. PMID: 22740791 Free PMC article. - Correction of murine SCID-X1 by lentiviral gene therapy using a codon-optimized IL2RG gene and minimal pretransplant conditioning.
Huston MW, van Til NP, Visser TP, Arshad S, Brugman MH, Cattoglio C, Nowrouzi A, Li Y, Schambach A, Schmidt M, Baum C, von Kalle C, Mavilio F, Zhang F, Blundell MP, Thrasher AJ, Verstegen MM, Wagemaker G. Huston MW, et al. Mol Ther. 2011 Oct;19(10):1867-77. doi: 10.1038/mt.2011.127. Epub 2011 Jul 12. Mol Ther. 2011. PMID: 21750532 Free PMC article.
References
- J Virol. 1988 Oct;62(10):3795-801 - PubMed
- Mol Cell Biol. 1987 Oct;7(10):3775-84 - PubMed
- Cell. 1989 Mar 24;56(6):979-86 - PubMed
- Science. 1986 Dec 12;234(4782):1409-13 - PubMed
- Cell. 1987 Dec 24;51(6):975-85 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources